Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro. (Record no. 14318071)

MARC details
000 -LEADER
fixed length control field 01713 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514161002.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200407s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0066-4804
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1128/AAC.47.11.3644-3646.2003
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tremblay, Cécile L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040706
245 00 - TITLE STATEMENT
Title Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Antimicrobial agents and chemotherapy
Date of publication, distribution, etc. Nov 2003
300 ## - PHYSICAL DESCRIPTION
Extent 3644-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-HIV Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dioxolanes
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Viral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enfuvirtide
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV Envelope Protein gp41
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV Infections
General subdivision virology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV Protease Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV-1
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peptide Fragments
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Purine Nucleosides
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reverse Transcriptase Inhibitors
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Poulin, Danielle L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hicks, Jennifer L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Selliah, Subajini
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chamberland, Annie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giguel, Françoise
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kollmann, Christopher S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chou, Ting Chao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dong, Huajin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hirsch, Martin S
773 0# - HOST ITEM ENTRY
Title Antimicrobial agents and chemotherapy
Related parts vol. 47
-- no. 11
-- p. 3644-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1128/AAC.47.11.3644-3646.2003">https://doi.org/10.1128/AAC.47.11.3644-3646.2003</a>
Public note Available from publisher's website

No items available.